Equity in vaccine trials for higher weight people? A rapid review of weight-related inclusion and exclusion criteria for COVID-19 clinical trials
10.3390/vaccines9121466
Saved in:
Main Authors: | Campbell, Jessica, Sutherland, Juliet, Bucknall, Danielle, O’hara, Lily, Heywood, Anita, Hobbs, Matthew, Ballantyne, Angela, Gray, Lesley |
---|---|
Other Authors: | DEAN'S OFFICE (MEDICINE) |
Format: | Article |
Published: |
MDPI
2022
|
Subjects: | |
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/233003 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
The immune response to 6-monthly versus annual standard dose inactivated trivalent influenza vaccination in older people: study protocol for a randomised clinical trial
by: Young, Barnaby, et al.
Published: (2017) -
COVID-19 vaccination intention and vaccine characteristics influencing vaccination acceptance: a global survey of 17 countries
by: Wong, Li Ping, et al.
Published: (2022) -
Human papilomavirus (HPV) vaccine for Southeast Asian countries
by: No information provided
Published: (2011) -
Hyporesponsiveness to re-challenge dose following pneumococcal polysaccharide vaccine at 12 months of age, a randomized controlled trial
by: Russell, F.M., et al.
Published: (2014) -
Circulating vaccine-derived poliovirus: A menace to the end game of polio eradication
by: Ming, L.C., et al.
Published: (2021)